SPP1 deficiency resulted in a significant reduction of mammary tumor growth and lung metastasis when treated with paclitaxel (Fig 6B and C) as well as combination treatment with doxorubicin (also known as adriamycin) and cyclophosphamide (AC regimen, Fig 6D–F; Appendix Fig S9B). Here, SPP1 is linked to breast cancer.